Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.39
Delayed Data
As of May 26
 -0.01 / -0.71%
Today’s Change
1.04
Today|||52-Week Range
1.85
-2.80%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.39
Day’s range1.38 - 1.40
Volume40,754
Average volume (3 months)424,314
Market cap$133.9M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...-0.17-4.93%
EVGNEvogene Ltd+0.19+3.81%
PTGXProtagonist Therapeu...-0.37-4.31%
KDMNKadmon Holdings Inc-0.02-0.81%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts